1. Home
  2. CRSR vs DRUG Comparison

CRSR vs DRUG Comparison

Compare CRSR & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$5.74

Market Cap

616.0M

Sector

Technology

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$73.41

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSR
DRUG
Founded
1994
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
616.0M
707.1M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
CRSR
DRUG
Price
$5.74
$73.41
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$8.50
$124.00
AVG Volume (30 Days)
1.4M
86.4K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
87.37
N/A
EPS
N/A
N/A
Revenue
$1,472,480,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.86
N/A
52 Week Low
$4.48
$23.18
52 Week High
$10.29
$123.75

Technical Indicators

Market Signals
Indicator
CRSR
DRUG
Relative Strength Index (RSI) 54.46 45.79
Support Level $5.39 $71.04
Resistance Level $6.19 $84.29
Average True Range (ATR) 0.25 4.14
MACD 0.01 -0.14
Stochastic Oscillator 61.03 34.46

Price Performance

Historical Comparison
CRSR
DRUG

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: